TrialCardiovascular diabetology2020

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.

Helen M Colhoun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.